Chronic migraine prevention with topiramate

Journal of Headache and Pain

Volumn 7, Issue 4, 2006, Pages 185-187

  Peres, Mario F P ^a,b   Mercante, J P P ^a   Tanuri, F C ^a   Nunes, M ^a   Zukerman, E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Antiepileptic drugs; Chronic migraine; Prevention; Topiramate

Indexed keywords

TOPIRAMATE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; ION CHANNEL;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DISEASE CONTROL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; PARESTHESIA; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; TRANSFORMED MIGRAINE; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION; BRAIN; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MIDDLE AGED; MIGRAINE; PATHOPHYSIOLOGY;

ADULT; ANTICONVULSANTS; BRAIN; CHRONIC DISEASE; COGNITION DISORDERS; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; FRUCTOSE; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; PARESTHESIA; RECEPTORS, GABA-A; TREATMENT OUTCOME;

EID: 33846817400     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-006-0339-6     Document Type: Article

References (10)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 41:646-657
2. Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190-196
3. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24[Suppl 1]:1-160
4. Diener HC, Tfelt-Hansen P, Dahlof C et al (MIGR-003 Study Group) (2004) Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 251:943-950
5. Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group (2004) Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61:490-495
6. Brandes JL, Saper JR, Diamond M et al; MIGR-002 Study Group (2004) Topiramate for migraine prevention: A randomized controlled trial. JAMA 291:965-973
7. Silvestrini M, Bartolini M, Coccia M et al (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23:820-824
8. Gallai V, Alberti A, Gallai B et al (2003) Glutamate and nitric oxide pathway in chronic daily headache: Evidence from cerebrospinal fluid. Cephalalgia 23:166-174
9. Silberstein SD, Goadsby PJ (2002) Migraine: Preventive treatment. Cephalalgia 22:491-512
10. Peres MF, Zukerman E, Senne Soares CA et al (2004) Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24:735-739